At BIOHOPE we research and develop precision medicine IVD tools for chronic inflammatory conditions. Our lead product, IMMUNOBIOGRAM®, is a novel IVD kit which allows to optimize the immunosuppressive therapy in patients with kidney transplantation and in the future for other autoimmune diseases.
THE BIG CHALLENGE
CHRONIC INFLAMMATION remains treated with immunosuppressive drugs mostly based on clinical guidelines, drug blood levels, and trial/error approaches. Inflammatory diseases are clearly lacking a tool to determine the potency (efficacy) of immunosuppressive drugs over the immune cells of the patients, which are actually the target cells of the immunosuppressants/ immunomodulators.
ONE TO ONE
PRECISION MEDICINE is the current major trend to maximize health outcomes in chronic medical conditions. This means that the time of “one drug for all” is over, instead, human diversity responses must be considered. Different patients need different drugs, and this is the driver of new medical management.
QUALITY OF LIFE
The IMMUNOBIOGRAM® is the only In Vitro Diagnostic test allowing the selection of the optimal immunosuppressive therapy (combination of drugs / dosage) for each patient at a specific point in time. More than 22 million patients worldwide can benefit from this unique technology.
IMMUNOBIOGRAM® Precision Medicine to tailor immunosuppressive therapies.